Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
Zhuoshan HuangXiao-Dong ZhuangShao-Zhao ZhangYiquan HuangLianxiong YuanAiwen LinLeile TangZhenyu XiongOdong ChristopherYang ChenBingyuan WuYesheng LingSuhua LiQiang JieLonggen XiongXiaoxian QianXin-Xue LiaoJinlai LiuPublished in: BMJ open (2023)
ChiCTR2200063191.
Keyphrases
- study protocol
- open label
- patients undergoing
- randomized controlled trial
- clinical trial
- phase iii
- phase ii
- coronary artery disease
- coronary artery
- percutaneous coronary intervention
- phase ii study
- double blind
- antiplatelet therapy
- placebo controlled
- direct oral anticoagulants
- squamous cell carcinoma
- radiation therapy
- aortic stenosis
- cross sectional
- transcatheter aortic valve replacement
- aortic valve